Chen, Han <br/><br/>
Nanoerythropoietin is 10-times more effective than regular erythropoietin in neuroprotection in a neonatal rat model of hypoxia and ischemia.  [electronic resource] 

 -  Stroke  Mar 2012 
 - 884-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1524-4628 
<br/><br/><label>Standard No.: </label>10.1161/STROKEAHA.111.637090  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Animals, Newborn<br/>Behavior, Animal--drug effects<br/>Brain Ischemia--drug therapy<br/>Cerebral Infarction--drug therapy<br/>Erythropoietin--administration & dosage<br/>Excipients<br/>Female<br/>Hypoxia, Brain--drug therapy<br/>Injections, Intraperitoneal<br/>Lactic Acid<br/>Male<br/>Nanoparticles<br/>Nervous System Diseases--prevention & control<br/>Neuroprotective Agents<br/>Organ Size--physiology<br/>Polyglycolic Acid<br/>Polylactic Acid-Polyglycolic Acid Copolymer<br/>Postural Balance--physiology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Recombinant Proteins<br/>Rotarod Performance Test